FINO2
CAS No. 869298-31-7
FINO2( —— )
Catalog No. M35322 CAS No. 869298-31-7
FINO2 is a potent ferroptosis-inducing compound that inhibits GPX4 activity. It functions as a stable oxidant, effectively oxidizing ferrous iron and demonstrating stability across varying pH levels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 79 | Get Quote |
|
| 5MG | 123 | Get Quote |
|
| 10MG | 202 | Get Quote |
|
| 25MG | 330 | Get Quote |
|
| 50MG | 490 | Get Quote |
|
| 100MG | 683 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFINO2
-
NoteResearch use only, not for human use.
-
Brief DescriptionFINO2 is a potent ferroptosis-inducing compound that inhibits GPX4 activity. It functions as a stable oxidant, effectively oxidizing ferrous iron and demonstrating stability across varying pH levels.
-
DescriptionFINO2 is a potent ferroptosis inducer. FINO2 inhibits GPX4 activity. FINO2 is a stable oxidant that oxidizes ferrous iron and stable at varying pH levels. FINO2 causes widespread lipid peroxidation.
-
In VitroFINO2 (10 μM; 24 h) induce ferroptosis and shows iron dependence of lipid peroxidation in HT-1080 cells.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetFerroptosis
-
RecptorFerroptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869298-31-7
-
Formula Weight256.38
-
Molecular FormulaC15H28O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (195.02 mM; Ultrasonic )
-
SMILESCC(C)(C)[C@H]1CC[C@]2(CC(C)(CCO)OO2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gaschler MM, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018 May;14(5):507-515. ?
molnova catalog
related products
-
BCP-T.A
BCP-T.A is an ferroptosis inducer that acts by binding to GPX4.
-
Imidazole ketone era...
Imidazole ketone erastin (IKE, Ferroptosis inducer IKE) is a potent, metabolically stable inhibitor of system xc- and inducer of ferroptosis potentially suitable for in vivo applications.
-
PRLX-93936 HCL
PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
Cart
sales@molnova.com